|
Levitra
or call it a sex-in-16-minute pill is now the talk of the
town in U.S. , as it has been approved for sale by FDA. In
case you missed the media blitz or recent news update, the
world's second largest pharmaceuticals company has finally
received the approval nod from the FDA for sale in the U.S
market on the 19th of August, 2003.
It is Six years since Pfizer launched Viagra and now a new
improved version, as a potent Viagra rival, has found its way
into the US market. Levitra is a new generation anti-impotence
pill that works wonder for Erectile Dysfunction (ED) problems
by targeting a key enzyme that controls blood flow to the penis.
Levitra, the new revolutionary drug to treat ED was launched
in the major markets of Europe on February 5, 2003 . The leading
pharmaceutical companies Bayer and GlaxoSmithKline, through a
worldwide co-promotion and co-development agreement market
Levitra.
The name Levitra was derived from
"le", the French masculine pronoun, and "vita",
Latin for life after selecting by eliminating almost 700 possible
names. GSK claims that Levitra is superior to Viagra - studies
showed that most Levitra takers were able to have satisfying
sex within 16 minutes, compared with a wait of up to an hour
for Viagra users.
Levitra works by blocking an enzyme known as PDE-5, which
affects the blood flow to the penis. Phosphodiesterase type
5 (PDE-5) is the predominate enzyme found in human penile
erectile tissue and is associated with erections. PDE-5 inhibitors
such as Levitra typically work by blocking this enzyme to
enhance or prolong the erectile process.
In trials involving 1,020 men with erectile dysfunction who
took the drug for one year, the average success rate in maintaining
erections improved to 87 percent from 14 percent with the 10
mg dose and to 86 percent from 16 percent with the 20 mg dose.
|
